Ajo LP Boosts Stock Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)

AJO LP grew its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 22.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 144,056 shares of the company’s stock after purchasing an additional 26,560 shares during the period. AJO LP owned approximately 0.28% of Prestige Consumer Healthcare worth $4,309,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of PBH. Norges Bank acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at $18,328,000. Dimensional Fund Advisors LP boosted its holdings in shares of Prestige Consumer Healthcare by 11.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,049,957 shares of the company’s stock valued at $125,062,000 after acquiring an additional 420,265 shares in the last quarter. LSV Asset Management boosted its holdings in shares of Prestige Consumer Healthcare by 183.1% during the 4th quarter. LSV Asset Management now owns 491,784 shares of the company’s stock valued at $15,186,000 after acquiring an additional 318,043 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 4.0% during the 4th quarter. BlackRock Inc. now owns 6,457,359 shares of the company’s stock valued at $199,402,000 after acquiring an additional 248,243 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its holdings in shares of Prestige Consumer Healthcare by 23.3% during the 4th quarter. Acadian Asset Management LLC now owns 1,235,502 shares of the company’s stock valued at $38,153,000 after acquiring an additional 233,793 shares in the last quarter.

Several research analysts have commented on the company. TheStreet downgraded Prestige Consumer Healthcare from a “c” rating to a “d+” rating in a report on Friday, May 10th. Zacks Investment Research raised Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a report on Tuesday, April 16th. CIBC reaffirmed a “hold” rating and set a $84.00 target price on shares of Prestige Consumer Healthcare in a report on Monday, May 27th. ValuEngine raised Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a report on Monday, April 29th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and set a $97.00 target price on shares of Prestige Consumer Healthcare in a report on Friday, March 15th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $57.77.

Shares of NYSE:PBH traded up $0.84 during midday trading on Monday, reaching $32.52. The company’s stock had a trading volume of 541,500 shares, compared to its average volume of 507,441. The firm has a market capitalization of $1.64 billion, a price-to-earnings ratio of 11.70, a price-to-earnings-growth ratio of 1.80 and a beta of 0.93. The company has a quick ratio of 1.43, a current ratio of 2.37 and a debt-to-equity ratio of 1.64. The stock has a 50 day moving average of $30.33. Prestige Consumer Healthcare Inc has a fifty-two week low of $26.25 and a fifty-two week high of $41.76.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, May 9th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.02. The company had revenue of $241.03 million for the quarter, compared to the consensus estimate of $237.22 million. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.67%. The firm’s revenue was down 5.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.62 EPS. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc will post 2.81 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

See Also: Growth and Income Funds

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.